Account

Peer review reports

From: A prospective, single-centre, randomised study evaluating the clinical, imaging and immunological depth of remission achieved by very early versus delayed Etanercept in patients with Rheumatoid Arthritis (VEDERA)

Original Submission
13 May 2015	Submitted	Original manuscript
	Author responded	Author comments
Resubmission - Version 2
	Submitted	Manuscript version 2
	Author responded	Author comments
	Reviewed	Reviewer Report
	Reviewed	Reviewer Report
	Reviewed	Reviewer Report
Resubmission - Version 3
	Submitted	Manuscript version 3
	Author responded	Author comments
	Reviewed	Reviewer Report
	Reviewed	Reviewer Report
Resubmission - Version 4
	Submitted	Manuscript version 4
Publishing
2 Feb 2016	Editorially accepted
5 Feb 2016	Article published	10.1186/s12891-016-0915-0

Learn about peer review

Back to article page